Savara Inc (NASDAQ:SVRA) shares are rising 8% after an interim data presentation for Aironite in pulmonary hypertension (PH) left investors excited with the …
Savara Inc (NASDAQ:SVRA) announced that it has received guidance from the FDA on the clinical program requirements for a New Drug Application submission …
Mast Therapeutics Inc (NYSEMKT:MSTX) and Savara, a privately held pharmaceutical firm aimed at treating rare respiratory diseases captivated the attention of investors in …
